A detailed history of Yousif Capital Management, LLC transactions in Staar Surgical CO stock. As of the latest transaction made, Yousif Capital Management, LLC holds 19,405 shares of STAA stock, worth $517,725. This represents 0.01% of its overall portfolio holdings.

Number of Shares
19,405
Previous 19,945 2.71%
Holding current value
$517,725
Previous $949,000 24.13%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$29.97 - $47.42 $16,183 - $25,606
-540 Reduced 2.71%
19,405 $720,000
Q2 2024

Jul 31, 2024

SELL
$38.07 - $52.25 $82,840 - $113,696
-2,176 Reduced 9.84%
19,945 $949,000
Q1 2024

Apr 26, 2024

SELL
$27.67 - $39.61 $62,810 - $89,914
-2,270 Reduced 9.31%
22,121 $846,000
Q4 2023

Feb 01, 2024

BUY
$30.6 - $43.78 $5,967 - $8,537
195 Added 0.81%
24,391 $761,000
Q3 2023

Oct 30, 2023

BUY
$39.39 - $58.12 $5,672 - $8,369
144 Added 0.6%
24,196 $972,000
Q2 2023

Aug 02, 2023

SELL
$50.45 - $72.82 $34,558 - $49,881
-685 Reduced 2.77%
24,052 $1.26 Million
Q1 2023

May 02, 2023

SELL
$51.25 - $79.34 $3,843 - $5,950
-75 Reduced 0.3%
24,737 $1.58 Million
Q4 2022

Jan 09, 2023

SELL
$46.82 - $76.2 $21,537 - $35,052
-460 Reduced 1.82%
24,812 $0
Q3 2022

Nov 04, 2022

SELL
$70.55 - $111.58 $155,421 - $245,810
-2,203 Reduced 8.02%
25,272 $1.78 Million
Q2 2022

Aug 01, 2022

BUY
$50.24 - $80.48 $137,406 - $220,112
2,735 Added 11.05%
27,475 $1.95 Million
Q1 2022

May 12, 2022

SELL
$57.98 - $93.5 $46,731 - $75,361
-806 Reduced 3.16%
24,740 $1.98 Million
Q4 2021

Jan 31, 2022

BUY
$88.02 - $127.79 $2.25 Million - $3.26 Million
25,546 New
25,546 $2.33 Million

Others Institutions Holding STAA

About STAAR SURGICAL CO


  • Ticker STAA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 48,038,300
  • Market Cap $1.28B
  • Description
  • STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...
More about STAA
Track This Portfolio

Track Yousif Capital Management, LLC Portfolio

Follow Yousif Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Yousif Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Yousif Capital Management, LLC with notifications on news.